ATLAS fair value
PLN 101.17
Below fair value · 36% discount
PCC Rokita stock price today, ATLAS forecast and fair value
Basic Materials · Chemicals · Warsaw Stock Exchange · Poland
Prices as of Oct 27, 2026 · PLN
PLN 101.17
Below fair value · 36% discount
53%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates PCC Rokita's fair value at about PLN 101.17 per share (reasonable range: PLN 79.15 to PLN 129.32). At PLN 64.60, the stock trades 36% below it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives PCC Rokita a 53% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between PLN 62.60 and PLN 67.20; in 9 out of 10, between PLN 58.79 and PLN 71.56. Estimated annual volatility is 20%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. PCC Rokita sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks PCR.WAR has traded between PLN 58.40 and PLN 74.40. Today it is 13.2% below that high and 11% above its low.
On the business: net margin is 7.4%; it trades at 9.6 times earnings.
Its beta is 0.59: it tends to move less than the market.
PCC Rokita SA designs, produces, and sells chemical products in Poland, Germany, the European Union, rest of Europe, the United States, Asia, and internationally. It operates through five segments: Polyurethanes, Chlorine Derivatives, Other Chemical Activities, Energy, and Other Activities.
Want to see everything about PCC Rokita?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About PLN 101.17 per share according to ATLAS (reasonable range: PLN 79.15 to PLN 129.32). With the stock at PLN 64.60, it is 36% below it.
53%: close to a coin flip. In half of the simulated outcomes, PCR.WAR ends the month between PLN 62.60 and PLN 67.20.
PCC Rokita's market capitalization is PLN 1.3B. Its price-to-earnings (P/E) ratio is 9.6: you pay PLN 9.56 for each PLN 1.00 of yearly earnings.
Yes. PCR.WAR's current dividend yield is 4.22% at today's price (PLN 64.60).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy